Electrophysiology – Products

Metrion Biosciences announced it has received notification from the MHRA that the Company is now a member of the UK GLP Compliance Monitoring Programme.

In collaboration with CSEM, 3Brain AG has announced an exciting 3D microchip for their brain-on-chip portfolio.

FUJIFILM Irvine Scientific, Inc. has announced the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that provides the ideal balance between ease of use and protection.

Download this app note to discover how patch-clamp can be used as part of an integrated risk assessment in first-in-human studies as well as later stages of clinical development.

Metrion Biosciences Limited has announced that the Company has moved to larger, custom designed laboratory and office premises at Granta Park, Cambridge, UK. The new headquarters will allow the Company to significantly expand its range of services and cell lines.

MEGIN is pleased to announce the acquisition of a TRIUX™ neo by The Centre For Cognitive Neuroimaging at the Institute for Neuroscience and Psychology at the University of Glasgow. This research facility will continue its role as the only MEG site in Scotland, continuously supporting neuroimaging related research.

Axol Bioscience Ltd, and CENSO Biotechnologies have announced that the two companies have signed a merger agreement. The new entity will be a provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets.

Download this app note to learn more about automated patch clamp and the benefits of using it in drug discovery.

Axol Bioscience (Axol), a biotechnology company specializing in the use of stem cell technology, today announced the expansion of its service offering, with the introduction of multi-electrode array (MEA) screening for human induced pluripotent stem cell (hiPSC)-derived cells.

Metrion Biosciences has contributed to two new papers that focus on the application of improved cardiac safety testing protocols and recommendations for best practice for the drug discovery industry.